07 Jan 2001

Ergo-Kranit® mono (Ergo-Kranit® mono 2 mg Tabletten) - Deutschland

Updated: 07 Jan 2001

Ergo-Kranit® mono 2 mg

Anfallskupierung der Migräne und anderer gefäßbedingter Kopfschmerzen.

Ergo-Kranit® mono Description, Presentation and Dosage

Ergo-Kranit® mono Description

Ergo-Kranit® mono Drug Class Description

Einzelstoffe

Ergo-Kranit® mono Drug Description

1 Tbl. enth.: Ergotamintartrat 2 mg.

Ergo-Kranit® mono Generic Name

Ergo-Kranit® mono 2 mg Tabletten

Ergo-Kranit® mono Presentation

Ergo-Kranit® mono Presentation

Ergo-Kranit® mono 2 mg

Ergo-Kranit® mono Manufacturer

Krewel Meuselbach

Related Learning Zones

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Ergo-Kranit® mono Dosage

Ergo-Kranit® mono Adult Dosage

Calciumarachinat, Lactose, Mikrokristalline Cellulose, Weinsäure, Crospovidon.

Ergo-Kranit® mono Precautions, Reactions and Contraindications

Ergo-Kranit® mono Special Precautions

Ergo-Kranit® mono Special Precautions

M 65

Ergo-Kranit® mono Adverse Reactions

Ergo-Kranit® mono Adverse Reactions

M 65

Related Drugs - Neurological Disorders

Back to top